Nanotechnology in Formulation of Tumor-Targeted Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 56
Special Issue Editors
Interests: drug repurposing; cancer epigenetics; multidrug resistance; drug transporters; gene regulation; platinum-based anticancer drugs
Special Issues, Collections and Topics in MDPI journals
Interests: chemistry; material sciences; nanotechnology; drug delivery; hydrogel; nanoparticle drug formulation; scaffolds; polymers; tissue engineering; catalysis; energy technology; electro or photocatalysis; advanced materials; characterization; spectroscopy; microscopy; chromatography; data analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has had a significant impact on various industries and fields of research, on everyday life, and on medicine. Nanoparticles are generally defined as particles of matter with a size ranging between 1 and 100 nm. One area of nanotechnology research focuses on the use of nanoparticles in applications that range from basic to advanced research. Because the size and surface properties of nanoparticles are important physical parameters that affect their behavior, the precise analysis of particle size is essential for research and development. The success of nanotechnology in targeted drug delivery is primarily attributed to their enhanced in vivo distribution, the good dispersion of nanoparticles within the body due to their small size, the effective delivery of drugs to target sites, and the absorption of poorly soluble drugs.
This Special Issue aims to address the impact of nanotechnology and nanomaterials on the development of drugs and the formulation of tumor-targeted drug delivery systems. Original research articles and reviews are welcome. The scope of this Special Issue includes, but is not limited to, the following topics:
- nanotechnology in medicine and scientific research
- nano-based targeted drug delivery systems
- nanoparticle formulations
- tumor and cancer treatment
- metallic, organic, inorganic, and nanostructured polymeric materials
- porous scaffolds
- characterization and functionalization
- particle size distribution and analysis
- dynamic light scattering, electron microscopy, and spectroscopy
- chemistry, biology, and chromatography
- in vitro biodistributions and pharmacokinetics
- drug encapsulation and release profiles
- uptake, cell viability and cytotoxicity
- poorly soluble chemotherapeutic drugs, such as doxorubicin
- nanocarriers (liposomes and micelles)
We look forward to receiving your contributions.
Prof. Dr. Kenneth K. W. To
Dr. Bijay P. Chhetri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- formulations
- tumor and cancer treatment
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
